Skip to content

To study the diagnosis and treatment scheme and related mechanism of cervical spondylotic myelopathy guided by cervical dynamic MRI

To study the diagnosis and treatment scheme and related mechanism of cervical spondylotic myelopathy guided by cervical dynamic MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122024
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy

Interventions

traction parameters (such as traction Angle, weight, and time) were adjusted according to the MRI results:None
receiving other conservative treatment except traction:None

Sponsors

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for cervical spondylotic myelopathy: Refer to the relevant standards in "Surgery" (9th edition) and "Traditional Chinese Medicine Orthopedics and Traumatology," combined with clinical symptoms (limb numbness, weakness, unsteady walking), physical signs (hyperactive tendon reflexes, positive pathological signs), and cervical MRI imaging evidence (spinal cord compression). 2. Age 18-60 years (based on the age at the time of consultation), any gender. 3. Disease course >3 months (calculated from the first occurrence of CSM-related symptoms and confirmed diagnosis, based on the time recorded in the medical record under "chief complaint" and "current medical history"). 4. Received the corresponding treatment in previous diagnosis and treatment with complete records: patients in the experimental group previously received traction therapy, and all underwent dynamic MRI examination before traction to adjust traction parameters (angle, weight, time) according to imaging results; patients in the control group previously received conservative treatment other than traction (such as cervical physiotherapy, oral neurotrophic drugs, non-steroidal anti-inflammatory drugs, etc.), with complete treatment records. 5. No record of oral, intravenous, intramuscular, or soft tissue injection of glucocorticoids in the 4 weeks prior to receiving the corresponding treatment in this study.

Exclusion criteria

Exclusion criteria: 1. Participated in or are currently participating in other clinical studies within the past 3 months (as recorded in the medical record under "Clinical Study Participation History," "Informed Consent Form Signing Record," or based on investigator inquiry records). 2. Previously received standard non-surgical therapy (such as standardized cervical traction, systematic physical therapy, medication treatment, etc.) for at least 6 months without effect, and symptoms continue to worsen (determined based on previous treatment records and symptom descriptions and functional score changes in follow-up logs). 3. Medical records indicate patients who, during prior treatment, used interventions for the current study’s condition without authorization (e.g., experimental group additionally underwent cervical surgery, control group self-administered traction therapy). 4. History of severe cervical trauma (e.g., cervical fracture, dislocation) or cervical surgery (confirmed by "Past History" records and imaging results such as cervical X-ray, CT, MRI). 5. Pregnant or breastfeeding at the time of visit (based on medical records under "Marriage and Childbearing History" or "Medical History Inquiry Records"). 6. Laboratory results within 1 week prior to treatment indicating heart, liver, kidney, or hematopoietic function damage based on blood routine, liver function (ALT, AST), kidney function (creatinine, urea nitrogen), etc. (judged according to the reference ranges of the hospital laboratory). 7. Medical records clearly document a history of opioid analgesics (such as morphine, oxycodone), sedative-hypnotic drugs (such as diazepam, zolpidem), and alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Modified Japanese Orthopedic Association Cervical Spine and Spinal Cord Function Score;

Secondary

MeasureTime frame
Visual analogue scale score;Cervical disability index;

Countries

China

Contacts

Public ContactZhong Yuanming

The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine

guoguanyang2025@163.com+86 135 0771 5643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026